![Elizabeth Bhatt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Bhatt
President bij
SEPTERNA, INC.
Vermogen: 7 M $ op 31-08-2026
Profiel
Elizabeth P.
Bhatt is currently President & Chief Operating Officer at Septerna, Inc., a position starting in 2025.
Former positions include Independent Director at Locust Walk Acquisition Corp., Independent Director at eFFECTOR Therapeutics, Inc. from 2020 to 2024, Vice President-Corporate Development at Gilead Sciences, Inc. from 2016 to 2017, Chief Operating & Business Officer at Achaogen, Inc. from 2018 to 2019, and Chief Business & Strategy Officer at Applied Molecular Transport, Inc. from 2019 to 2022.
Education includes undergraduate studies at Pomona College and an MBA from Kellogg School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SEPTERNA, INC. 0,37% | 11-08-2026 | 174.209 ( 0,37% ) | 7 M $ | 31-08-2026 |
Actieve functies van Elizabeth Bhatt
| Bedrijven | Functie | Begin |
|---|---|---|
| SEPTERNA, INC. | President | 01-08-2025 |
Eerdere bekende functies van Elizabeth Bhatt
| Bedrijven | Functie | Einde |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Directeur/Bestuurslid | 21-06-2024 |
| APPLIED MOLECULAR TRANSPORT INC. | Corporate Officer/Principal | 31-05-2022 |
| ACHAOGEN | Operationeel Directeur | 30-06-2019 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-09-2017 |
| EFFECTOR THERAPEUTICS, INC. | Directeur/Bestuurslid | - |
Opleiding van Elizabeth Bhatt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
76
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
Locust Walk Acquisition Corp.
 Locust Walk Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
